TGT
50
-2
MPC
52
8
LB
38
-7
CMG
51
-3
EXC
53
6
MCD
67
2
ADP
69
-3
RCL
76
2
TXN
50
-3
UA
32
8
EFX
63
-6
MSI
72
2
PYPL
43
-4
SEE
38
-3
UPS
55
-6
NAVI
55
-2
BF.B
43
-7
NI
65
2
EQR
54
-2
UNH
53
-3
TGT
50
-2
MPC
52
8
LB
38
-7
CMG
51
-3
EXC
53
6
MCD
67
2
ADP
69
-3
RCL
76
2
TXN
50
-3
UA
32
8
EFX
63
-6
MSI
72
2
PYPL
43
-4
SEE
38
-3
UPS
55
-6
NAVI
55
-2
BF.B
43
-7
NI
65
2
EQR
54
-2
UNH
53
-3
Financhill
Back

First Trust IndXX NextG ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
67

NXTG
First Trust IndXX NextG ETF

Last Price:
86.57
Seasonality Move:
1.99%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
67
First Trust IndXX NextG ETF (NXTG) is a Buy

Is First Trust IndXX NextG ETF a Buy, Sell or Hold?

  • The current First Trust IndXX NextG ETF [NXTG] share price is $86.56. The Score for NXTG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • NXTG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NXTG Stock Price Chart

What is First Trust IndXX NextG ETF's stock price today?

  • The First Trust IndXX NextG ETF share price today is $86.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NXTG is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

NXTG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.79 Buy
Relative Strength Index (14 RSI): 59.74 Buy
Chaikin Money Flow: 2951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (84.16 - 86.02) Buy
Bollinger Bands (100): (79.07 - 84.81) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

NXTG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.94 Buy
20-day SMA: 85.23 Buy
50-day SMA: 83.67 Buy
200-day SMA: 79.31 Buy
8-day EMA: 85.9 Buy
20-day EMA: 85.12 Buy
50-day EMA: 83.84 Buy
200-day EMA: 79.39 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

First Trust IndXX NextG ETF Earnings Growth & NXTG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

First Trust IndXX NextG ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):